An Open-label, Randomised Multicenter Phase 3b Study to Determine the Confirmed Rate of Molecular Response ≥ 4 Log (MR4) at Two Years

NCT02174445 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
14
Enrollment
OTHER
Sponsor class

Stopped very slow recruitment rate and a lot of pat. didn't fulfil BCR-ABL requirements

Conditions

Interventions

Sponsor

Prof. Dr. Nikolas von Bubnoff

Collaborators